Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Fleshner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Surgical Oncology|March 8, 2025
ASO Author Reflections: Uptake of Completion Axillary Lymph Node Dissection in Post-Neoadjuvant Chemotherapy Breast Cancer PatientsKatherine Fleshner, May Lynn Quan
European Urology|January 14, 2022
Re: Changes in Prostate-specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningKatherine Fleshner, Sigrid V Carlsson
Nature Reviews. Urology|July 18, 2018
The USPSTF screening recommendation: a swinging pendulumKatherine Fleshner, Sigrid V Carlsson
Nature Reviews. Urology|December 21, 2016
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USAKatherine Fleshner, Sigrid V Carlsson, Monique J Roobol
JCO Clinical Cancer Informatics|January 18, 2019
Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology ClinicKatherine Fleshner, Amy Tin, Nicole Benfante, et al.
The Journal of Urology|April 7, 2016
Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate BiopsyKatherine Fleshner, Melissa Assel, Nicole Benfante, et al.
Annals of Surgical Oncology|February 19, 2025
Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant ChemotherapyKatherine Fleshner, Yuan Xu, Susan Isherwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 2, 2017
What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?Rashid Khalid Sayyid, Dharmendra Dingar, Katherine Fleshner, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Surgical Oncology|March 8, 2025
ASO Author Reflections: Uptake of Completion Axillary Lymph Node Dissection in Post-Neoadjuvant Chemotherapy Breast Cancer PatientsKatherine Fleshner, May Lynn Quan
European Urology|January 14, 2022
Re: Changes in Prostate-specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer ScreeningKatherine Fleshner, Sigrid V Carlsson
Nature Reviews. Urology|July 18, 2018
The USPSTF screening recommendation: a swinging pendulumKatherine Fleshner, Sigrid V Carlsson
Nature Reviews. Urology|December 21, 2016
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USAKatherine Fleshner, Sigrid V Carlsson, Monique J Roobol
JCO Clinical Cancer Informatics|January 18, 2019
Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology ClinicKatherine Fleshner, Amy Tin, Nicole Benfante, et al.
The Journal of Urology|April 7, 2016
Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate BiopsyKatherine Fleshner, Melissa Assel, Nicole Benfante, et al.
Annals of Surgical Oncology|February 19, 2025
Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant ChemotherapyKatherine Fleshner, Yuan Xu, Susan Isherwood, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 2, 2017
What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?Rashid Khalid Sayyid, Dharmendra Dingar, Katherine Fleshner, et al.
Pageof 1